Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding > The additional hetero ring is five-membered having ring nitrogen > Plural nitrogens in the additional five-membered hetero ring > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/254.05
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding > The additional hetero ring is five-membered having ring nitrogen > Plural nitrogens in the additional five-membered hetero ring
Description: Subject matter wherein the additional five-membered hetero ring contains at least two ring nitrogen atoms.

Sub-classes under this class:

Class Number	Class Name	Patents
514/254.07	Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding	221
514/254.06	Polycyclo ring system having the plural nitrogen containing additional five-membered hetero ring as one of the cyclos	325

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11

Patent Number	Title Of Patent	Date Issued
8658642	Arylsulfonamide CCR3 antagonists	Feb. 25, 2014
8642025	Hepatitis C virus inhibitors	Feb. 4, 2014
8623862	Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics	Jan. 7, 2014
8604022	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpipera- zin-1-yl)benzamide and salts thereof	Dec. 10, 2013
8598179	Pyrazole-carboxamide derivatives as P2Y12 antagonists	Dec. 3, 2013
8551985	Carbinol derivatives having heterocyclic linker	Oct. 8, 2013
8546374	Amino-tetrazoles analogues and methods of use	Oct. 1, 2013
8501781	Heteroarylpiperidine and -piperazine derivatives	Aug. 6, 2013
8492384	Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof	Jul. 23, 2013
8481535	Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT.sub.2A serotonin receptor	Jul. 9, 2013
8470829	Imidazolidine derivative and use thereof	Jun. 25, 2013
8450317	CXCR3 receptor antagonists	May. 28, 2013
8431563	Compounds that interact with glucokinase regulatory protein for the treatment of diabetes	Apr. 30, 2013
8426420	Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists	Apr. 23, 2013
8415346	Inhibitors of Janus kinases	Apr. 9, 2013
8410159	Imidazole compounds having pharmaceutical activity towards the sigma receptor	Apr. 2, 2013
8372807	Methods of modulating uric acid levels	Feb. 12, 2013
8372844	Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same	Feb. 12, 2013
8362004	Piperazine analogs as broad-spectrum influenza antivirals	Jan. 29, 2013
8343976	Compounds, compositions and methods comprising pyrazole derivatives	Jan. 1, 2013
8338405	Therapeutic piperazines	Dec. 25, 2012
8329703	Pyrazole compounds	Dec. 11, 2012
8324216	Substituted piperazines	Dec. 4, 2012
8314091	N-benzyl,N'-arylcarbonylpiperazine derivatives	Nov. 20, 2012
8314089	Substituted pyrazolamides and their use	Nov. 20, 2012
8299072	Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof	Oct. 30, 2012
8278307	Monocyclic Heteroaryl compounds	Oct. 2, 2012
8273341	Antiviral compounds	Sep. 25, 2012
8268830	Method of using diketopiperazines and composition containing them	Sep. 18, 2012
8263600	Antifungal composition with enhanced bioavailability	Sep. 11, 2012
8242117	5-membered heterocycle-based p38 kinase inhibitors	Aug. 14, 2012
8236806	Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same	Aug. 7, 2012
8222254	1, 2, 4-triazole derivatives as serotonergic modulators	Jul. 17, 2012
8207156	Substituted pyrazoline compounds, their preparation and use as medicaments	Jun. 26, 2012
8202872	Pyrazole derivatives as sigma receptor inhibitors	Jun. 19, 2012
8193176	Phenylpyrazole derivatives	Jun. 5, 2012
8163757	Immuno inhibitory pyrazolone compounds	Apr. 24, 2012
8148367	Renin inhibitors	Apr. 3, 2012
8138174	Compounds with a combination of cannabinoid CB.sub.1 antagonism and serotonin reuptake inhibition	Mar. 20, 2012
8138190	Diaza heterocyclic amide compounds and their uses	Mar. 20, 2012
8129391	N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpipera- zin-1-yl)benzamide and salts thereof	Mar. 6, 2012
8101618	1,4-substituted piperazine derivatives	Jan. 24, 2012
8093251	Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators	Jan. 10, 2012
8088368	Antiviral compounds	Jan. 3, 2012
8053457	3-imidazolyl-indoles for the treatment of proliferative diseases	Nov. 8, 2011
8039463	Piperazine derivatives as inhibitors of stearoyl-CoA desaturase	Oct. 18, 2011
8008299	Urotensin II receptor antagonists	Aug. 30, 2011
8003653	Imidazolidinone compounds useful as .beta.-secretase inhibitors for the treatment of Alzheimer's disease	Aug. 23, 2011
7989485	Imidazole compounds having pharmaceutical activity towards the sigma receptor	Aug. 2, 2011
7981896	Pyrazoles for the treatment of obesity and other CNS disorders	Jul. 19, 2011